They argue that FDA regulation would stifle innovation. “It is not in the best interest of patient care to delay innovation” to help treat cancer and other diseases, said Susan Van Meter ...

NPR's Ayesha Rascoe speaks with U.S. FDA Commissioner Robert Califf about ... But some patient advocacy groups are worried. They want more regulation of AI in the healthcare industry.

Special Communication: FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine. Image Credit: Sansoen Saengsakaorat / Shutterstock A Special Communication ...

The U.S. Supreme Court takes up the issue of vaping and e-cigarette regulation on Monday ... William Schultz, who served for five years as the FDA's deputy commissioner for policy in the 1990s ...